Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 10071290

Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1999 Mar
First author
Petrylak DP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Petrylak DP
      type
      Author
    2. name
      Macarthur RB
      type
      Author
    3. name
      O'Connor J
      type
      Author
    4. name
      Shelton G
      type
      Author
    5. name
      Judge T
      type
      Author
    6. name
      Balog J
      type
      Author
    7. name
      Pfaff C
      type
      Author
    8. name
      Bagiella E
      type
      Author
    9. name
      Heitjan D
      type
      Author
    10. name
      Fine R
      type
      Author
    11. name
      Zuech N
      type
      Author
    12. name
      Sawczuk I
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Petrylak DP
      type
      Author
    2. name
      Macarthur RB
      type
      Author
    3. name
      O'Connor J
      type
      Author
    4. name
      Shelton G
      type
      Author
    5. name
      Judge T
      type
      Author
    6. name
      Balog J
      type
      Author
    7. name
      Pfaff C
      type
      Author
    8. name
      Bagiella E
      type
      Author
    9. name
      Heitjan D
      type
      Author
    10. name
      Fine R
      type
      Author
    11. name
      Zuech N
      type
      Author
    12. name
      Sawczuk I
      type
      Author
    bibliography ids
    1. nci-bib-82a89d290793be7365b27c95
    book metadata
    content sha256
    d655625fc21eaae41cd4937ac31de90b9c4fed76c70d85e7faef58de5f29a57f
    document type
    citation
    dois
    1. 10.1200/JCO.1999.17.3.958
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:10071290
    immutable id
    pubmed:10071290@d655625fc21eaae41cd4937ac31de90b9c4fed76c70d85e7faef58de5f29a57f
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    3
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    958-67
    volume
    17
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      10071290
      provenance
      batch id
      322200bb755447812cbb
      provider
      NCBI PubMed ESummary
      record sha256
      3d52a201fc4cc31e6824811cc0027e4dc368f9724e17af900da00c16b1245170
      response sha256
      943a99f9971dfe66ed403e5c181642ea57c7276fe995e9a6a8c892602df084fa
      retrieved at
      2026-09-09T23:45:33.802271+00:00
      publication date
      display
      1999 Mar
      precision
      month
      year
      1999
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase I
      3. Journal Article
      4. Research Support, Non-U.S. Gov't
      5. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/10071290/
      title
      Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer.

      Preserved source evidence · Not medical advice